Search Results - "POURHASSAN, Hoda"

Positioning blinatumomab in the frontline of adult B-cell acute lymphoblastic leukemia treatment by Pourhassan, Hoda, Agrawal, Vaibhav, Pullarkat, Vinod, Aldoss, Ibrahim

“…Blinatumomab is a bispecific T cell engager that has shown efficacy in relapsed/refractory Philadelphia chromosome (Ph)-positive and Ph-negative acute…”
Get full text

Venetoclax in combination with a pediatric-inspired regimen for the treatment of newly diagnosed adults with Philadelphia chromosome-negative acute lymphoblastic leukemia by Aldoss, Ibrahim, Zhang, Jianying, Shimamoto, Kathryn, Saygin, Caner, Robbins, Marjorie, Agrawal, Vaibhav, Aribi, Ahmed, Karaoglu, Diren Arda, Pourhassan, Hoda, Koller, Paul, Ali, Haris, Blackmon, Amanda, Otoukesh, Salman, Sandhu, Karamjeet, Ball, Brian, Artz, Andrew S., Al Malki, Monzr M., Salhotra, Amandeep, Tinajero, Jose, Gu, Zhaohui, Lagman, Ian, Velasquez, Michelle, Dang, Jacqueline, Becker, Pamela S., Afkhami, Michelle, Ghoda, Lucy, Stock, Wendy, Forman, Stephen J, Stein, Anthony, Marcucci, Guido, Pullarkat, Vinod

“…BCL-2 protein overexpression, common in B-cell acute lymphoblastic leukemia (B-ALL), including the Philadelphia (Ph)-like subtype, mediates leukemic cell…”
Get full text

Lack of association between FTO gene variations and metabolic healthy obese (MHO) phenotype: Tehran Cardio-metabolic Genetic Study (TCGS) by Sedaghati-khayat, Bahareh, Barzin, Maryam, Akbarzadeh, Mahdi, Guity, Kamran, Fallah, Mohammad-Sadegh, Pourhassan, Hoda, Azizi, Fereidoun, Daneshpour, Maryam S.

“…Background Obesity is currently an international epidemic and metabolic derangements pose these individuals at greater risk for future morbidity and mortality…”
Get full text

Autoimmune rhabdomyolysis and a multiorgan display of PD-1 inhibitor induced immune related adverse events during treatment of metastatic melanoma by Pourhassan, Hoda Z, Tryon, David, Schaeffer, Brett, Mirshahidi, Hamid, Wong, John

“…Programmed death-1 (PD-1) inhibitors are among the immunotherapies that have revolutionized our approach to treating several cancers. These novel agents act by…”
Get full text

Identifying monoclonal gammopathy of undetermined significance from electronic health records by Tanenbaum, Hilary C., Birmann, Brenda M., Bertrand, Kimberly A., Teras, Lauren R., Krishnan, Amrita Y., Pourhassan, Hoda, Goldsmith, Scott, Cannavale, Kimberly, Wang, Sophia S., Chao, Chun R.

“…Background Monoclonal gammopathy of undetermined significance (MGUS) precedes multiple myeloma (MM). Use of electronic health records may facilitate…”
Get full text

Cell Type-Specific Induction and Inhibition of Apoptosis by Herpes Simplex Virus Type 2 ICP10 by HAN, Jin-Young, MILLER, Sara A, WOLFE, Teresa M, POURHASSAN, Hoda, JEROME, Keith R

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

SOHO State of the Art Updates and Next Questions | Asparaginase—Understanding and Overcoming Toxicities in Adults with ALL by Aldoss, Ibrahim, Pourhassan, Hoda, Douer, Dan

“…The adoption of pediatric-inspired regimens in young adults with newly diagnosed acute lymphoblastic leukemia (ALL) has significantly improved their survival…”
Get full text

Glucocorticoid Therapy in Acute Lymphoblastic Leukemia: Navigating Short-Term and Long-Term Effects and Optimal Regimen Selection by Pourhassan, Hoda, Murphy, Lindsey, Aldoss, Ibrahim

“…Purpose of Review Glucocorticoids are a mainstay in acute lymphoblastic leukemia treatment and lack of early response is predictive for overall disease…”
Get full text

Optimizing CAR‐T cell therapy in adults with B‐cell acute lymphoblastic leukemia by Agrawal, Vaibhav, Murphy, Lindsey, Pourhassan, Hoda, Pullarkat, Vinod, Aldoss, Ibrahim

“…Chimeric antigen receptor T‐cell (CAR‐T) therapy has demonstrated unprecedented success in the treatment of various hematologic malignancies including relapsed…”
Get full text

Clearance of bone marrow mast cells after hypomethylating agent and venetoclax for systemic mastocytosis associated with myeloid neoplasia by Pourhassan, Hoda, Kim, Young, Pullarkat, Vinod

“…Systemic mastocytosis (SM) results from clonal proliferation of neoplastic mast cells that infiltrate bone marrow and other organs. A major subset of patients…”
Get full text

Important Considerations in the Intensive Care Management of Acute Leukemias by Pourhassan, Hoda, Kareem, Waasil, Agrawal, Vaibhav, Aldoss, Ibrahim

“…In the realm of hematologic disorders, acute leukemia is approached as an emergent disease given the multitude of complications and challenges that present…”
Get full text

Asparaginase: How to Better Manage Toxicities in Adults by Pourhassan, Hoda, Douer, Dan, Pullarkat, Vinod, Aldoss, Ibrahim

“…Purpose of Review This review aims to help oncologists who predominantly treat adults better understand and manage asparaginase associated toxicities and…”
Get full text

Delaying Pegaspargase Administration during Induction in Adults with Acute Lymphoblastic Leukemia by Tinajero, Jose, Xu, Sharon, Nguyen, Tina, Ngo, Dat, Stein, Anthony, Koller, Paul B., Agrawal, Vaibhav, Pourhassan, Hoda, Pullarkat, Vinod, Aldoss, Ibrahim

“…Background Pegaspargase (PEG-asparaginase) is a key drug in pediatric-inspired regimens that is utilized frequently in young adults with acute lymphoblastic…”
Get full text

Delaying pegaspargase during induction in adults with acute lymphoblastic leukaemia is associated with lower risk of high‐grade hepatotoxicity without adversely impacting outcomes by Tinajero, Jose, Xu, Sharon, Ngo, Dat, Li, Shanpeng, Palmer, Joycelynne, Nguyen, Tina, Stein, Anthony, Koller, Paul, Agrawal, Vaibhav, Pourhassan, Hoda, Murphy, Lindsey, Forman, Stephen, Douer, Dan, Marcucci, Guido, Pullarkat, Vinod, Aldoss, Ibrahim

“…Pegaspargase is a key drug for the treatment of younger adults with acute lymphoblastic leukaemia (ALL). Pegaspargase‐associated hepatotoxicity is most common…”
Get full text

Treatment of relapsed or refractory FLT-3 acute myelogenous leukemia with a triplet regimen of hypomethylating agent, venetoclax, and gilteritinib by Ngo, Dat, Tinajero, Jose, Li, Shanpeng, Palmer, Joycelynne, Pourhassan, Hoda, Aribi, Ahmed, Nakamura, Ryotaro, Stein, Anthony, Marcucci, Guido, Salhotra, Amandeep, Sandhu, Karamjeet, Pullarkat, Vinod, Ball, Brian, Koller, Paul

“…Relapsed or refractory (R/R) acute myeloid leukemia (AML) with FMS-like tyrosine kinase 3 (FLT3) mutations remains a difficult and hard to treat entity…”
Get full text

Therapy‐related acute lymphoblastic leukaemia in women with antecedent breast cancer by Pourhassan, Hoda, Zhang, Jianying, Tinajero, Jose, Pullarkat, Vinod, Agrawal, Vaibhav, Koller, Paul, Al Malki, Monzr, Aribi, Ahmed, Salhotra, Amandeep, Sandhu, Karamjeet, Ali, Haris, Stein, Anthony, Marcucci, Guido, Forman, Stephen, Aldoss, Ibrahim

“…Summary Therapy‐related acute lymphoblastic leukaemia (tr‐ALL) is a disease entity attributed to previous exposure to chemotherapy and/or radiation for…”
Get full text

The characterization and the impact of CSF pleocytosis during blinatumomab therapy for adult acute lymphoblastic leukemia by Ngo, Dat, Tinajero, Jose, Song, Joo Y, Ma, Huiyan, Quirk, Elizabeth, Koller, Paul, Pourhassan, Hoda, Agrawal, Vaibhav, Stein, Anthony S, Marcucci, Guido, Murphy, Lindsey, Forman, Stephen J, Pullarkat, Vinod, Aldoss, Ibrahim

“…Reactive pleocytosis in the CSF has been observed with blinatumomab but has not been well-described. We performed a retrospective study of 88 patients who…”
Get full text

Tyrosine kinase inhibitor maintenance following chimeric antigen receptor T‐cell therapy in Philadelphia chromosome‐positive acute lymphoblastic leukaemia by Othman, Tamer, Koller, Paul, Pourhassan, Hoda, Agrawal, Vaibhav, Ngo, Dat, Tinajero, Jose, Ali, Haris, Cai, Ji‐Lian, Mei, Matthew, Aribi, Ahmed, Stein, Anthony S., Marcucci, Guido, Forman, Stephen J., Pullarkat, Vinod, Aldoss, Ibrahim

Get full text

Clinical management of a patient following a granulocyte transfusion from a donor positive for COVID-19 by Woo, Jennifer S, Zhuang, Lefan, Jackson, Ryan, Wang, Shirong, Agrawal, Vaibhav, Blackmon, Amanda, Pourhassan, Hoda, Yuan, Shan

“…Granulocyte transfusions are indicated for patients with severe neutropenia and evidence of bacterial or fungal infection who are unresponsive to standard…”
Get full text

Comparing transplant outcomes in ALL patients after myeloablative conditioning in mismatch-related or unrelated donor settings by Otoukesh, Salman, Yang, Dongyun, Mokhtari, Sally, Pourhassan, Hoda, Agrawal, Vaibhav, Arslan, Shukaib, Amanam, Idoroenyi, Ball, Brian, Koller, Paul, Salhotra, Amandeep, Sandhu, Karamjeet, Aribi, Ahmed, Artz, Andrew, Aldoss, Ibrahim, Pullarkat, Vinod, Ali, Haris, Blackmon, Amanda, Becker, Pamela, Curtin, Peter, Stewart, Forrest, Smith, Eileen, Stein, Anthony, Marcucci, Guido, Forman, Stephen J., Nakamura, Ryotaro, Al Malki, Monzr M.

“…The optimal myeloablative conditioning regimen for ALL patients undergoing hematopoietic cell transplant (HCT) with an alternative donor is unknown. We…”
Get full text